3a. Research exempted from review
Research may be exempted from review if:
- is negligible risk research; and
- involves the use of existing collections of data or records that contain only non-identifiable data about human beings.
An HRE application is required to be submitted for an exemption to be formally applied.
3b. Expedited review
HRE applications that are deemed to be negligible or low risk may be eligible for expedited review. However, where a person's reactions exceed discomfort and become distress, the project is "more than low" risk.
What's involved?
|
Research that is deemed to be low risk or negligible risk and does not fall under any of the National Statement chapters listed for a full HREC review, can be sent to expedited review.
The expedited review is completed by at least two experienced people (drawn from a small pool of 5 people consisting of the HREC Chair, Deputy Chairs, and the Ethics Coordinators).
|
How long does it take?
|
The expedited review is an ongoing process that operates between February and November. Applicants should allow up to 20 University business days for an expedited review. If there are significant comments, then these will need to be addressed by the research team and the application resubmitted to the ethics office for them to check that the review feedback has been addressed. |
3c. More than low risk HRE applications
HRE applications that are deemed to be more than low risk are not eligible for expedited review and must be review by the full UniSQ HREC. Refer to the UniSQ HREC meeting dates for information on submission timelines.
The UniSQ HREC must review research that involves any of the following:
- Women who are pregnant and/ or the human fetus
- people highly dependent on medical care who may be unable to give consent
- people with cognitive impairment, an intellectual disability, or a mental illness
- people who may be involved in illegal activities
- Aboriginal and Torres Strait Islander Peoples
- animal-to-human xenotransplantation
- genomic research
- forensic or involuntary patients
- clinical trials
- active concealment or planned deception
- exposing illegal activity
- participants on the DSM-5 scale
- significant psychological risk
- accessing sensitive health information or data
- prisoners or people on parole
- participants who would not ordinarily be considered vulnerable; however, are vulnerable due to the nature of the research
- collection of biological materials, i.e. blood, saliva, etc
- hospital patients
- research being conducted by parents/ guardians with own children
- economic impact due to participation in the research, i.e. loss of income, loss of employment, etc
- sensitive and/or contentious issues, i.e. suicide, eating disorders, etc.
- significant reputational risk, i.e. this could be to the participants, research team or the University
If your research involves any of the following, please contact the Ethics Office to discuss further; prior to commencing an application:
- Animal-to-human xenotransplantation
- genomic research
- forensic or involuntary patients
- clinical trials
- research being conducted by parents/guardians with own children.